Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Martindale

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1980
Technetium-99m antimony colloid for bone-marrow imagingA A Martindale, J M Papadimitriou, J H Turner
Nuclear Medicine Communications|July 29, 1999
Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphyP J Cameron, P F Klemp, A A Martindale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastasesJ H Turner, P G Claringbold, E L Hetherington, et al.
Progress in Clinical and Biological Research|January 1, 1990
Technetium-99m leucocyte labelling using a lyophilised stannous fluoride colloid kitA A Martindale, M J Peris, J H Turner, et al.
Nuclear Medicine Communications|May 1, 1992
153Sm-EDTMP and melphalan chemoradiotherapy regimen for bone marrow ablation prior to marrow transplantation: an experimental model in the ratJ H Turner, P G Claringbold, J D Berger, et al.
European Journal of Nuclear Medicine|January 1, 1987
Samarium-153 chelate localization in malignant melanomaJ H Turner, A A Martindale, G C de Witt, et al.
European Journal of Nuclear Medicine|January 1, 1989
Samarium-153 EDTMP therapy of disseminated skeletal metastasisJ H Turner, A A Martindale, P Sorby, et al.
Nuclear Medicine Communications|July 1, 1994
166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pigJ H Turner, P G Claringbold, P F Klemp, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1980
Technetium-99m antimony colloid for bone-marrow imagingA A Martindale, J M Papadimitriou, J H Turner
Nuclear Medicine Communications|July 29, 1999
Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphyP J Cameron, P F Klemp, A A Martindale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastasesJ H Turner, P G Claringbold, E L Hetherington, et al.
Progress in Clinical and Biological Research|January 1, 1990
Technetium-99m leucocyte labelling using a lyophilised stannous fluoride colloid kitA A Martindale, M J Peris, J H Turner, et al.
Nuclear Medicine Communications|May 1, 1992
153Sm-EDTMP and melphalan chemoradiotherapy regimen for bone marrow ablation prior to marrow transplantation: an experimental model in the ratJ H Turner, P G Claringbold, J D Berger, et al.
European Journal of Nuclear Medicine|January 1, 1987
Samarium-153 chelate localization in malignant melanomaJ H Turner, A A Martindale, G C de Witt, et al.
European Journal of Nuclear Medicine|January 1, 1989
Samarium-153 EDTMP therapy of disseminated skeletal metastasisJ H Turner, A A Martindale, P Sorby, et al.
Nuclear Medicine Communications|July 1, 1994
166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pigJ H Turner, P G Claringbold, P F Klemp, et al.
Pageof 1